These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
167 related items for PubMed ID: 32638332
21. Speg interactions that regulate the stability of excitation-contraction coupling protein complexes in triads and dyads. Lee CS, Jung SY, Yee RSZ, Agha NH, Hong J, Chang T, Babcock LW, Fleischman JD, Clayton B, Hanna AD, Ward CS, Lanza D, Hurley AE, Zhang P, Wehrens XHT, Lagor WR, Rodney GG, Hamilton SL. Commun Biol; 2023 Sep 14; 6(1):942. PubMed ID: 37709832 [Abstract] [Full Text] [Related]
23. Binding partners of the kinase domains in Drosophila obscurin and their effect on the structure of the flight muscle. Katzemich A, West RJ, Fukuzawa A, Sweeney ST, Gautel M, Sparrow J, Bullard B. J Cell Sci; 2015 Sep 15; 128(18):3386-97. PubMed ID: 26251439 [Abstract] [Full Text] [Related]
24. SPEG: a key regulator of cardiac calcium homeostasis. Campbell H, Aguilar-Sanchez Y, Quick AP, Dobrev D, Wehrens XHT. Cardiovasc Res; 2021 Aug 29; 117(10):2175-2185. PubMed ID: 33067609 [Abstract] [Full Text] [Related]
26. SPEG-deficient skeletal muscles exhibit abnormal triad and defective calcium handling. Huntoon V, Widrick JJ, Sanchez C, Rosen SM, Kutchukian C, Cao S, Pierson CR, Liu X, Perrella MA, Beggs AH, Jacquemond V, Agrawal PB. Hum Mol Genet; 2018 May 01; 27(9):1608-1617. PubMed ID: 29474540 [Abstract] [Full Text] [Related]
27. Striated muscle preferentially expressed genes alpha and beta are two serine/threonine protein kinases derived from the same gene as the aortic preferentially expressed gene-1. Hsieh CM, Fukumoto S, Layne MD, Maemura K, Charles H, Patel A, Perrella MA, Lee ME. J Biol Chem; 2000 Nov 24; 275(47):36966-73. PubMed ID: 10973969 [Abstract] [Full Text] [Related]
28. New aspects of obscurin in human striated muscles. Carlsson L, Yu JG, Thornell LE. Histochem Cell Biol; 2008 Jul 24; 130(1):91-103. PubMed ID: 18350308 [Abstract] [Full Text] [Related]
30. The potential of obscurin as a therapeutic target in muscle disorders. Randazzo D, Pierantozzi E, Rossi D, Sorrentino V. Expert Opin Ther Targets; 2017 Sep 24; 21(9):897-910. PubMed ID: 28756711 [Abstract] [Full Text] [Related]
31. Early incorporation of obscurin into nascent sarcomeres: implication for myofibril assembly during cardiac myogenesis. Borisov AB, Martynova MG, Russell MW. Histochem Cell Biol; 2008 Apr 24; 129(4):463-78. PubMed ID: 18219491 [Abstract] [Full Text] [Related]
32. Myosin light chain kinase steady-state kinetics: comparison of smooth muscle myosin II and nonmuscle myosin IIB as substrates. Alcala DB, Haldeman BD, Brizendine RK, Krenc AK, Baker JE, Rock RS, Cremo CR. Cell Biochem Funct; 2016 Oct 24; 34(7):469-474. PubMed ID: 27528075 [Abstract] [Full Text] [Related]
33. Disruption of striated preferentially expressed gene locus leads to dilated cardiomyopathy in mice. Liu X, Ramjiganesh T, Chen YH, Chung SW, Hall SR, Schissel SL, Padera RF, Liao R, Ackerman KG, Kajstura J, Leri A, Anversa P, Yet SF, Layne MD, Perrella MA. Circulation; 2009 Jan 20; 119(2):261-8. PubMed ID: 19118250 [Abstract] [Full Text] [Related]
34. Alterations in cytoskeletal and Ca2+ cycling regulators in atria lacking the obscurin Ig58/59 module. Grogan A, Huang W, Brong A, Kane MA, Kontrogianni-Konstantopoulos A. Front Cardiovasc Med; 2023 Jan 20; 10():1085840. PubMed ID: 37304957 [Abstract] [Full Text] [Related]